A randomized, placebo-controlled, double-blind study to confirm the reversal of hepatorenal syndrome type 1 with terlipressin: the REVERSE trial design (vol 4, pg 39, 2012)

被引:0
|
作者
Boyer, T. D.
Medicis, J. J.
Pappas, S. C.
Potenziano, J.
Jamil, K.
机构
关键词
D O I
10.2147/OAJCT.S36089
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:59 / 59
页数:1
相关论文
共 50 条
  • [31] Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome
    Glaze, Daniel G.
    Neul, Jeffrey L.
    Kaufmann, Walter E.
    Berry-Kravis, Elizabeth
    Condon, Sean
    Stoms, George
    Oosterholt, Sean
    Della Pasqua, Oscar
    Glass, Larry
    Jones, Nancy E.
    Percy, Alan K.
    Beisang, Arthur
    Benke, Timothy
    Feyma, Timothy
    Heydemann, Peter
    Jones, Mary
    Marsh, Eric D.
    Peters, Sarika
    Peterson, Myron Skip
    Sahin, Mustafa
    Skinner, Steve
    Standridge, Shannon
    NEUROLOGY, 2019, 92 (16) : E1912 - E1925
  • [32] Randomized, double-blind, placebo-controlled crossover study of donepezil in Down syndrome
    Kishnani, PS
    Spiridigliozzi, GA
    Heller, JH
    Sullivan, JA
    Crissman, BG
    Hauser, E
    Grambow, SC
    Doraiswamy, PM
    Krishnan, RR
    NEUROLOGY, 2005, 64 (06) : A106 - A106
  • [33] THE CONFIRM STUDY: A NORTH AMERICAN RANDOMIZED CONTROLLED TRIAL (RCT) OF TERLIPRESSIN PLUS ALBUMIN FOR THE TREATMENT OF HEPATORENAL SYNDROME TYPE 1 (HRS-1)
    Wong, Florence
    Curry, Michael P.
    Reddy, K. Rajender
    Rubin, Raymond A.
    Porayko, Michael K.
    Gonzalez, Stevan A.
    Mumtaz, Khalid
    Lim, Nicholas
    Simonetto, Douglas A.
    Sharma, Pratima
    Sanyal, Arun J.
    Mayo, Marlyn J.
    Frederick, Richard Todd
    Pappas, Stephen Chris
    Jamil, Khurram
    HEPATOLOGY, 2019, 70 (06) : 1480A - 1481A
  • [34] Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study
    Varenna, Massimo
    Braga, Vania
    Gatti, Davide
    Iolascon, Giovanni
    Frediani, Bruno
    Zucchi, Francesca
    Crotti, Chiara
    Nannipieri, Fabrizio
    Rossini, Maurizio
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [35] A randomized, placebo-controlled, double-blind trial of paroxetine controlled release (CR) in irritable bowel syndrome
    Masand, P. S.
    Peindl, K.
    Krulewicz, S.
    Varia, I.
    Patkar, A. A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S137 - S137
  • [36] A Double-Blind, Randomized, Placebo-Controlled Trial of Paroxetine Controlled-Release in Irritable Bowel Syndrome
    Masand, Prakash S.
    Pae, Chi-Un
    Krulewicz, Stan
    Peindl, Kathleen
    Mannelli, Paolo
    Varia, Indu M.
    Patkar, Ashwin A.
    PSYCHOSOMATICS, 2009, 50 (01) : 78 - 86
  • [37] Shuhe granule for insomnia: study protocol for a double-blind, randomized, placebo-controlled trial
    Gao, Yu
    Chen, Xiangbin
    Li, Yuxi
    Shen, Yuchuan
    Chen, Xinyi
    Xu, Qing
    Peng, Mengling
    Xu, Wen
    Yuan, Jiamin
    Hu, Yuanyuan
    Chen, Xiankun
    Xu, Biyun
    Yang, Zhimin
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [38] A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea (vol 142, pg 805, 2005)
    DuPont, HL
    Jiang, ZD
    Okhuysen, PC
    Ericsson, CD
    de la Cabada, FJ
    Ke, S
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (03) : 239 - 239
  • [40] A Randomized, Double-Blind, Placebo-Controlled Trial of Fluvoxamine in Patients With Schizophrenia A Preliminary Study
    Niitsu, Tomihisa
    Fujisaki, Mihisa
    Shiina, Akihiro
    Yoshida, Taisuke
    Hasegawa, Tadashi
    Kanahara, Nobuhisa
    Hashimoto, Tasuku
    Shiraishi, Tetsuya
    Fukami, Goro
    Nakazato, Michiko
    Shirayama, Yukihiko
    Hashimoto, Kenji
    Iyo, Masaomi
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (05) : 593 - 601